Obermatt
See Similar Stocks →

Scholar Rock

NSQ:SRRK · US80706P1030
BiotechnologySmall

360° View

67
Price/Sales13
Price/Earnings81
Price/Book100
Dividend Yield—
Revenue Growth—
Profit Growth9
Capital Growth49
TSR 52w41
Leverage20
Liquidity37
Refinancing81
Combined50
Analyst Opinions75
Pro Holdings87
Opinion Changes79
Market Pulse81

Profile

CountryUSA
IndustryBiotechnology
SizeSmall
TypePublic Company
ExchangeNASDAQGS
Founded2017
Employees288
Websitescholarrock.com
ISINUS80706P1030
Last UpdateApr 2, 2026
Index & Theme
ImmunologyCentral Nervous SystemNeurologyNeuroscienceGenetic DisorderOncologyChronic DiseasesHematologyGenetics

Description

Scholar Rock Holding Corporation and its subsidiaries (Scholar Rock) operate as a global biopharmaceutical company. The company is dedicated to improving the lives of children and adults with spinal muscular atrophy (‘SMA’) and additional rare, seve…

Analysis

Scholar Rock's 360° View rank of 67 places it above its peer average — better than 67% of its true peers.

It's lagging on growth (24) and looks cheap versus peers (89). On safety it is carrying more balance-sheet risk (27), and the market shows strongly positive sentiment (100). Taken together, its Combined rank of 50 reads as below its peer average.

360° rank · history

1007550250
67
2026

All-time high

73

Mar 2026

All-time low

67

Jun 2026

Average rank

70

across all years

Detailed & Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history.

Current202520242023
Price/Sales
13
—
—
—
Price/Earnings
81
—
—
—
Price/Book
100
—
—
—
Dividend Yield
—
—
—
—
Value (overall)
89
—
—
—

Cells are coloured by rank band (red weak → green strong). Sentiment & 360° history begins 2023.

Similar Stocks

The companies this stock is ranked against.

Compare Scholar Rock with its peers
Shattuck Labs
NSQ:STTK
50
CountryUSA
IndustryBiotechnology
SizeSmall
Full Stock Analysis →
Schrödinger
NSQ:SDGR
14
CountryUSA
IndustryHealth Care Technology
SizeMedium
Full Stock Analysis →
Geron
NSQ:GERN
22
CountryUSA
IndustryBiotechnology
SizeSmall
Full Stock Analysis →
Nuvectis Pharma
NAQ:NVCT
—
CountryUSA
IndustryBiotechnology
SizeSmall
Full Stock Analysis →
Nurix Therapeutics
NMQ:NRIX
18
CountryUSA
IndustryBiotechnology
SizeSmall
Full Stock Analysis →
Adaptive Biotechnologies
NSQ:ADPT
20
CountryUSA
IndustryLife Sciences Tools & Services
SizeMedium
Full Stock Analysis →

Make Sense of the Ranks

Every rank runs 1–100 against true peers. Higher is always better.

360° View
1 · Watch OutGood· 100
Value
1 · ExpensiveGood Value· 100
Quality
1 · Weak FundamentalsHigh Quality· 100
Growth
1 · Tough TimesHigh Growth· 100
Safety
1 · High LeverageWell-Financed· 100
Sentiment
1 · SkepticismPositive· 100
Learn More →